Septicemia Clinical Trial
Official title:
Monitoring Mitophagy In Myeloid Cells Upon Intensive Care
Severe infections (sepsis) are a frequent cause of admission to the intensive care unit. Sepsis represent a significant risk for the health of patients in the short and medium term. Sepsis are notably linked to a change in the function of immune cells. In some patients, a state of pseudo-dormancy of monocyte and macrophage immune cells, called myeloid cell immunosuppression, is observed. This situation, which leads to a worsening of the infection, must be avoided because it represents a danger for the patient, even during antibiotic therapy. At present, these events are still very poorly understood. Research is needed to understand how the immunosuppression of myeloid cells occurs in order to adapt existing treatments or to find new ones. Laboratory work on animal models of sepsis has shown that this state of myeloid cell immunosuppression is closely linked to a modification of energy production by myeloid cells (monocytes and macrophages). The function of the mitochondria ("energy factory" of the cells) in these cells is impaired. Thus, restoring mitochondrial function in myeloid cells could be a therapeutic solution against the immunosuppression of myeloid cells during severe sepsis. The aim of this study is to verify whether alterations in mitochondrial function in myeloid cells occur in both patients with and without bacterial infection.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Enrolling by invitation |
NCT04764058 -
Efficacy and Safety of Colistin Based Antibiotic Therapy
|
Phase 1/Phase 2 | |
| Completed |
NCT03088865 -
Evaluation of an Internal Hospital Practice: The Effect of Altered Test Tubes Sampling Order on Blood Culture Contamination Rates
|
N/A | |
| Completed |
NCT00046072 -
A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe Sepsis
|
Phase 2 | |
| Completed |
NCT01520597 -
National Study on Listeriosis and Listeria
|
||
| Recruiting |
NCT03929159 -
Correlating MicroRNA Changes With Sepsis Outcomes
|
||
| Completed |
NCT03943719 -
Clinical Impact of the FilmArray Blood Culture Identification Panel Performed on Positive Blood Cultures From Intensive Care Patients With Septicemia
|
||
| Completed |
NCT00901940 -
Understanding the Immune Response to Meningitis Vaccines
|
Phase 3 | |
| Not yet recruiting |
NCT03583762 -
Time to Appropriate Antibiotic Between Using Microarray Assay and Mass Spectrometry Technique
|
N/A | |
| Completed |
NCT02988414 -
Diagnosis of Bacteremia/Septicemia and Culture Negative Endocarditis by the Karius Sequencing-Based Infectious Disease Diagnostic Assay
|
||
| Completed |
NCT02102087 -
Study to Evaluate the Effectiveness of the Initial Specimen Diversion Device
|
N/A | |
| Recruiting |
NCT05045963 -
Impact of Aminoglycosides in Hypotensive Septic Oncology Patients
|
||
| Terminated |
NCT02093494 -
Study to Evaluate the Effectiveness of the Initial Specimen Diversion Device When Collected Through Peripheral Intravenous Catheters
|
N/A | |
| Active, not recruiting |
NCT02069028 -
Effectiveness of Different Interventions for Implementing Surviving Sepsis Campaign (SSC) Guidelines on Compliance and Mortality: Systematic Review and Meta-analysis
|
N/A | |
| Recruiting |
NCT00258869 -
Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests
|
N/A | |
| Completed |
NCT05358912 -
Efficacy of Targeted Abdominal Perfusion Pressure in Septic Shock
|
Phase 4 | |
| Recruiting |
NCT05893420 -
A Rapid Diagnostic of Risk in Hospitalized Patients Using Machine Learning
|
N/A | |
| No longer available |
NCT04636554 -
Personalized Phage Treatment in Covid-19 Patients With Bacterial Co-Infections Microbials for Pneumonia or Bacteremia/Septicemia
|
||
| Completed |
NCT00146432 -
Immunoadsorption of LPS, C5a and IL-6 in Severe Sepsis and Septic Shock (ISASS-1)
|
Phase 2/Phase 3 |